- Category
- Micro (2023-24)
- Udyam number
- UDYAM-MH-17-0104288

Cancri Pharma (OPC) Private Limited
About Cancri Pharma (OPC) Private Limited
Data last updated:
Cancri Pharma (OPC) Private Limited is a one person company based in Vasai, Maharashtra, India. It was incorporated on 12 April 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U47721MH2023OPC400789.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by director Neelam Manoj Tiwari.
Its latest financial statements are for the year ended 31 March 2025. The registered office is at 305 Sai Jivdani Apt. B/H Ganesh Mandir V.S. Marg Virar, Vasai, Maharashtra, India – 401303.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.89 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹10,487 (net margin -1.8%) and EBITDA of -₹10,487 (EBITDA margin -1.8%).
Cancri Pharma (OPC) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0104288).
Company details
Recognitions & Rankings of Cancri Pharma
Contact details
Cancri Pharma (OPC) Private Limited's registered office is in Vasai, Maharashtra.
- Registered Address305 Sai Jivdani Apt. B/H Ganesh Mandir V.S. Marg Virar, Vasai, Maharashtra, India – 401303
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cancri Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Cancri Pharma (OPC) Private Limited, buy the company report.
Financials of Cancri Pharma (OPC) Private Limited
FY 2025 filings availableCancri Pharma (OPC) Private Limited reported revenue of ₹5.89 Lakh (up 208% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 208% in the latest year. EBITDA rose 61% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹10,487 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹10,487 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -1.8% | |
| Net Profit Margin | -1.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Cancri Pharma (OPC) Private Limited, buy the company report.
Board of directors of Cancri Pharma (OPC) Private Limited
Cancri Pharma has 1 director on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelam Manoj Tiwari | Director | 12 Apr 2023 | 3 Years 7 Months | Current |
Peer comparison
Cancri Pharma (OPC) Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Farben Dyes & Chemicals Private Limited | ₹6.05 Lakh (FY 2023) | -67.0% | Bangalore, Karnataka, India | |||
| Pureair Analytics Private Limited | ₹6.01 Lakh (FY 2025) | Thiruvananthapuram, Kerala, India | ||||
| Rexha Pharmaceuticals Private Limited | ₹6.01 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Omega Woven Mills Pvt Ltd | ₹6 Lakh (FY 2025) | Thane, Maharashtra, India | ||||
| Realise Crop Care Private Limited | ₹5.9 Lakh (FY 2025) | 556.0% | Malkapur, Maharashtra, India | |||
| Cancri Pharma (OPC) Private Limitedthis company | ₹5.89 Lakh (FY 2025) | -₹10,487 | -1.8% | 208.0% | Vasai, Maharashtra, India | |
| Super Strong Timber Protection Private Limited | ₹5.57 Lakh (FY 2025) | 6.0% | Delhi, India | |||
| Kamalpur Merchants Pvt.Ltd. | ₹5.55 Lakh (FY 2025) | 42.0% | Kolkata, West Bengal, India | |||
| Duma Lifesciences Private Limited | ₹5.42 Lakh (FY 2025) | 3562.0% | Roorkee, Uttarakhand, India | |||
| Gorura Fertilizers and Chemicals Private Limited | ₹5.41 Lakh (FY 2024) | 754.0% | Baramati, Maharashtra, India | |||
| SSV Agrotech Private Limited | ₹5.35 Lakh (FY 2025) | 1.0% | Satara, Maharashtra, India |
To see the full peer comparison of Cancri Pharma (OPC) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cancri Pharma (OPC) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cancri Pharma (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cancri Pharma (OPC) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cancri Pharma (OPC) Private Limited has 1 board change on record since 2023: 1 appointment. The latest: Neelam Manoj Tiwari was appointed as Director on 12 Apr 2023.
Frequently asked questions
Cancri Pharma is an active company based in Vasai, Maharashtra, India. It was incorporated on 12 April 2023 (3+ years old) and is registered under CIN U47721MH2023OPC400789.
Cancri Pharma has 1 current director:
- Neelam Manoj Tiwari - Director
The latest financial statements of Cancri Pharma on record with the MCA are for the year ended 31 March 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Cancri Pharma is U47721MH2023OPC400789. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cancri Pharma was incorporated on 12 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Cancri Pharma by revenue are Farben Dyes & Chemicals Private Limited, Pureair Analytics Private Limited, Rexha Pharmaceuticals Private Limited, Omega Woven Mills Pvt Ltd, Realise Crop Care Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Neelam Manoj Tiwari was appointed as Director on 12 Apr 2023.
Yes, Cancri Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0104288).
The registered office of Cancri Pharma is at 305 Sai Jivdani Apt. BH Ganesh Mandir V.S. Marg Virar, Vasai, Maharashtra, India – 401303.
Cancri Pharma can be reached at its registered office: 305 Sai Jivdani Apt. BH Ganesh Mandir V.S. Marg Virar, Vasai, Maharashtra, India – 401303.
Cancri Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.

